Barely Significant
← all phrases

“highly significant”

132,143 sentences · 132,143 papers · 160,126 search hits before verification · confirmed specimen

Sighted at

p=0.09

Listed by Hankins (2013)

In the literature

highly significantP = 0.01830.4× alphaqualifiedgold
When setting VD as the baseline reference, being born via iCD emerged as a highly significant independent predictor of elevated BMI percentiles (Estimate = 6.81, P = 0.0183, Linear Mixed-Effects Model), whereas aCD showed no significant difference from VD (P = 0.1026, Linear Mixed-Effects Model).
highly significantP = 0.01840.4× alphaqualifiedgold
Not only concentration and observation time but also the interaction between concentration and time had a highly significant influence on mean mortality (F = 3.34, df = 4, P = 0.0184; F = 12.51, df = 4, P < 0.001; F = 4.94, df = 9, p < 0.0002), respectively indicating that the effect of ivermectin concentration on tick mortality depended on observation time.
highly significantp = 0.01890.4× alphaqualifiedgold
Post-hoc Šídák’s test showed that feeding with 0.3% CPZ caused a highly significant decrease in the TDM in week 1 ( p = 0.0189), week 3 ( p < 0.0001), and week 5 ( p = 0.0001) compared with the control group during the demyelination stage ( Figure 3A ).
highly significantP = .0190.4× alphaqualifiedgold
In the subgroup with a complete or partial radiologic response to latest ARPI (n = 29), darolutamide achieved a highly significant rPFS prolongation (HR, 0.35 [95% CI, 0.14 to 0.87]; P = .019) and OS (HR, 0.26 [95% CI, 0.06 to 1.19]; P = .063), while in the subgroup with stable or progressive disease as best response to latest ARPI (n = 61), no significant between-arm difference was observed (HR, 0.7 [95% CI, 0.36 to 1.35]; P = .28; HR, 0.97 [95% CI, 0.39 to 2.43]; P = .95; Appendix Fig A 2 , online only).
highly significantP =0.0190.4× alphaqualifiedgold
In the multivariate analysis with adjustments for blood data excluding CA125, only LDH remained highly significant ( P =0.019), although stage and cytoreduction outcome were independent predictors of a poorer PFI after adjustments for group, age, FIGO stage, histological type, and cytoreduction outcome ( P <0.001 and <0.001, respectively; Table 3 ).
highly significantp = 0.0190.4× alphaqualifiedgold
Working Memory Update Task—N-Back Task The results of the updating function test showed that in terms of reaction time, the main effect of group was highly significant, F(1, 28) = 8.131, p = 0.019, η p 2 = 0.475, indicating that there was a significant difference in the updating function between the control and the exercise group of college students.
highly significantp=0.0190.4× alphaqualifiedgold
The risk factors causing depressive and anxiety symptoms were evaluated through univariate analysis and logistic regression. Results In addition to American Urological Association risk stratification, depressive symptoms were another independent risk factor for recurrence in NMIBC patients (HR: 2.493, 95% CI: 1.048–5.930, p=0.039), and the increase in the recurrence rate was highly significant in intermediate-risk patients (HR: 8.496, 95% CI: 2.178–33.138, p=0.019).
highly significantP = .0190.4× alphaqualifiedgold
Also, the difference between the 2 groups, namely patients with schizophrenia and healthy controls, was highly significant in identifying HLFT block I (antonyms; P = .019), block I-distractors (I-D) ( P = .014), block II homonyms (H) ( P = .016), and block II hyponym plus distractor combinations (H0 + D) ( P = .002) ( table 5 ).
highly significantP =0.0190.4× alphaqualifiedgold
The relationship between the responsiveness of patients with ESCC to treatment and these markers was analyzed, and the results indicated a highly significant relationship between the response to chemoradiotherapy in patients with ESCC and NLR ( P =0.019) or CNP ( P =0.016); however, there was no significant relationship between sensitivity to chemoradiotherapy in patients with ESCC and PLR ( P =0.148; Table 3 ).
highly significantp = 0.0190.4× alphaqualifiedgold
The primary endpoint in the PLATO trial exhibited highly significant disagreement favoring ticagrelor for vascular death (HR = 2.02; 95% CI: 1.1–3.64; p = 0.019); MI (HR = 2.31; 95% CI: 2.79–43.94; p = 0.034); stroke (HR = 1.37; 95% CI: 2.66–63.28; p = 0.036); total events (HR = 2.51; 95% CI: 1.86–3.39; p = 0.01).